De-identified Health Data Market, By Type of Data, By Application, By End User, By Geography
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¼¼°è ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀåÀº 2025³â¿¡ 82¾ï 1,000¸¸ ´Þ·¯, 2032³â¿¡´Â 153¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2032³â ¿¬Æò±Õ 9.3%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
º¸°í ¹üÀ§
º¸°í¼ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ
2024³â
2025³â ½ÃÀå ±Ô¸ð
82¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ
2020-2024³â
¿¹Ãø ±â°£
2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR
9.30%
2032³â °¡Ä¡ ¿¹Ãø
153¾ï 1,000¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀå Á¡À¯À²(%)
ºñ½Äº°È ÀÇ·á µ¥ÀÌÅÍ ½ÃÀåÀÇ ¼ºÀåÀº ½Å¾à °³¹ß ¹× Á¤¹ÐÀǷḦ À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿ Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ºñ½Äº°È´Â °Ç° µ¥ÀÌÅÍ ¼¼Æ®¿¡¼ À̸§, »ý³â¿ùÀÏ, Áֹεî·Ï¹øÈ£¿Í °°Àº ½Äº°ÀÚ¸¦ Á¦°ÅÇÏ¿© ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¿Í ±â¹Ð¼ºÀ» º¸ÀåÇÕ´Ï´Ù. À̸¦ ÅëÇØ ¿¬±¸ÀÚ ¹× »ý¸í°úÇÐ ±â¾÷µéÀº À±¸®¼ºÀ» ÈѼÕÇÏÁö ¾Ê°í »õ·Î¿î Ä¡·á¹ý °³¹ß ¹× ¿ªÇÐ ¿¬±¸¸¦ À§ÇØ ´ë·®ÀÇ °Ç° µ¥ÀÌÅ͸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î °Ç° ±â·ÏÀÇ µðÁöÅÐȰ¡ °¡¼Óȵʿ¡ µû¶ó 2Â÷ÀûÀ¸·Î Ȱ¿ë °¡´ÉÇÑ ºñ½Äº°È µ¥ÀÌÅÍÀÇ ¾çÀº Áõ°¡ÇÒ °ÍÀÔ´Ï´Ù.
½ÃÀå ¿ªÇÐ
°¡Ä¡ ±â¹Ý Ä¡·á, Ä¡·áÀÇ °³ÀÎÈ, µðÁöÅÐ Çコ ½ºÅ¸Æ®¾÷ÀÇ ¼ºÀå¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ Àü ¼¼°èÀûÀ¸·Î ºñ½Äº°È ÀÇ·á µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ Ç¥ÁØÈÀÇ ºÎÁ·°ú ÁöÀûÀç»ê±ÇÀ» µÑ·¯½Ñ ¸ðÈ£ÇÔÀÌ ½ÃÀåÀÇ ÀáÀç·ÂÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. °í±Þ ºÐ¼® ±â´ÉÀÇ °³¹ßÀº ±â¾÷µé¿¡°Ô Ç®¸µµÈ µ¥ÀÌÅÍ Àڻ꿡¼ ´õ ±íÀº ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Á¤ºÎÀÇ ¿ÀÇ µ¥ÀÌÅÍ °øÀ¯ ÀÌ´Ï¼ÅÆ¼ºêÀÇ È®´ë´Â ÀÌ·¯ÇÑ µ¥ÀÌÅÍ ¼¼Æ®¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹ Á¤ºÎ´Â Data.gov ¹× HealthData.gov¿Í °°Àº ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÅëÇØ °øÁߺ¸°Ç ¿¬±¸ÀÇ Åõ¸í¼º°ú Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ ´Ù¾çÇÑ °Ç° °ü·Ã µ¥ÀÌÅÍ ¼¼Æ®¿¡ ´ëÇÑ °³¹æÇü ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
¼¼°èÀÇ ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ º¸°í¼´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
ÁÖ¿ä Á¶»ç ´ë»ó ±â¾÷À¸·Î´Â IQVIA, Oracle(Cerner Corporation), Merative(Truven Health Analytics), Optum, Optum, BioTelemetry, Inc. LLC,Medidata Solutions,Evidation Health, Inc.,Komodo Health, Inc. Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, Huma Therapeutics µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¼¼°è ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ºñ½Äº°È ÀÇ·á µ¥ÀÌÅÍ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
½ÃÀå ¿ªÇÐ
¼ºÀå ÃËÁø¿äÀÎ
¼ºÀå ¾ïÁ¦¿äÀÎ
±âȸ
¿µÇ⠺м®
ÁÖ¿ä ¹ßÀü
±ÔÁ¦ ½Ã³ª¸®¿À
Á¦Ç° ¹ß¸Å/½ÂÀÎ
PEST ºÐ¼®
PORTER ºÐ¼®
ÀμöÇÕº´(M&A) ½Ã³ª¸®¿À
¾÷°è µ¿Çâ
Á¦4Àå ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀå, µ¥ÀÌÅÍ À¯Çüº°, 2020³â-2032³â
ÀÓ»ó µ¥ÀÌÅÍ
À¯Àüü µ¥ÀÌÅÍ
ȯÀÚ Àα¸Åë°è
ó¹æ µ¥ÀÌÅÍ
û±¸ µ¥ÀÌÅÍ
Çൿ µ¥ÀÌÅÍ
¿þ¾î·¯ºí ¹× ¼¾¼ µ¥ÀÌÅÍ
¿¬±¸ ¹× ȯÀÚ º¸°í µ¥ÀÌÅÍ
¿µ»ó µ¥ÀÌÅÍ
°Ë»ç µ¥ÀÌÅÍ
°Ç° »çȸÀû °áÁ¤ ¿äÀÎ(SDOH) µ¥ÀÌÅÍ
±âŸ
Á¦5Àå ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀå, ¿ëµµº°, 2020³â-2032³â
ÀÓ»ó Á¶»ç¿Í ½ÃÇè
°øÁßÀ§»ý
Á¤¹ÐÀÇ·á
ÀÇ·á °æÁ¦ ¹× ¼º°ú Á¶»ç(HEOR)
Áý´Ü°Ç°°ü¸®
Drug Discovery & Development
ÇコÄɾî ǰÁú Çâ»ó
º¸Çè Àμö ¹× ¸®½ºÅ© Æò°¡
±âŸ
Á¦6Àå ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â
Á¦¾àȸ»ç
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
ÀÇ·á Á¦°øÀÚ
º¸Çè»ç/ÀÇ·áºñ ÁöºÒÀÚ
¿¬±¸±â°ü
Á¤ºÎ±â°ü
±âŸ
Á¦7Àå ºñ½Äº°È °Ç° µ¥ÀÌÅÍ ½ÃÀå, Áö¿ªº°, 2020³â-2032³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
¾Æ½Ã¾ÆÅÂÆò¾ç
秵¾ÆÇÁ¸®Ä«
Á¦8Àå °æÀï ±¸µµ
IQVIA
Oracle(Cerner Corporation)
Merative(Truven Health Analytics)
Optum, Inc.
BioTelemetry, Inc.
Flatiron Health
Veradigm LLC
Medidata Solutions
Evidation Health, Inc.
Komodo Health, Inc.
Sundown Solutions, LLC
Clarify Health Solutions
Akrivia Health
Satori Cyber Ltd.
Tempus
nference
Ciox Health
HealthVerity
Zebra Medical Vision
Huma Therapeutics
Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×
Wheel of Fortune
¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
COM(Coherent Opportunity Map)
Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý
Âü°í ¹®Çå
Á¶»ç ¹æ¹ý
ÃâÆÇ»ç¿¡ ´ëÇØ
LSH
Global De-identified Health Data Market is estimated to be valued at USD 8.21 Bn in 2025 and is expected to reach USD 15.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 8.21 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
9.30%
2032 Value Projection:
USD 15.31 Bn
Figure. De-identified Health Data Market Share (%), By Region 2025
De-identified health data market growth is driven by increasing research and development activities for drug discovery and precision medicine. De-identification ensures patient privacy and confidentiality by removing identifiers such as name, date of birth, social security number, and others from health data sets. This allows researchers and life science companies to utilize large pools of health data for developing novel therapies and epidemiological studies without compromising on ethics. As digitization of health records accelerates across the world, there will be increase in amount of de-identified data available for secondary usage.
Market Dynamics
Rising focus on value-based care, personalization of treatment, and growth of digital health startups can boost demand for de-identified health data globally. However, lack of data standardization and ambiguity over intellectual property rights can hamper the market potential. Development of advanced analytics capabilities offers an opportunity for players to unlock deeper insights from pooled data assets. Growing open data sharing initiatives by governments can widen the access to these data sets. The U.S. government has launched initiatives like Data.gov and HealthData.gov that offers open access to a wide range of health-related datasets to encourage transparency and innovation in public health research.
Key features of the study
This report provides in-depth analysis of the global de-identified health data market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global de-identified health data market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IQVIA, Oracle (Cerner Corporation), Merative (Truven Health Analytics), Optum, Inc., BioTelemetry, Inc., Flatiron Health, Veradigm LLC, Medidata Solutions, Evidation Health, Inc., Komodo Health, Inc., Sundown Solutions, LLC, Clarify Health Solutions, Akrivia Health, Satori Cyber Ltd., Tempus, nference, Ciox Health, HealthVerity, Zebra Medical Vision, and Huma Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global de-identified health data market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global de-identified health data market
Market Segmentation
Type of Data Insights (Revenue, USD Bn, 2020 - 2032)
Clinical Data
Genomic Data
Patient Demographics
Prescription Data
Claims Data
Behavioral Data
Wearable and Sensor Data
Survey and Patient-Reported Data
Imaging Data
Laboratory Data
Social Determinants of Health (SDOH) Data
Others
Application Insights (Revenue, USD Bn, 2020 - 2032)
Clinical Research and Trials
Public Health
Precision Medicine
Health Economics and Outcomes Research (HEOR)
Population Health Management
Drug Discovery and Development
Healthcare Quality Improvement
Insurance Underwriting and Risk Assessment
Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
Pharmaceutical Companies
Biotechnology Firms
Healthcare Providers
Insurance Companies/Healthcare Payers
Research Institutions
Government Agencies
Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
IQVIA
Oracle (Cerner Corporation)
Merative (Truven Health Analytics)
Optum, Inc.
BioTelemetry, Inc.
Flatiron Health
Veradigm LLC
Medidata Solutions
Evidation Health, Inc.
Komodo Health, Inc.
Sundown Solutions, LLC
Clarify Health Solutions
Akrivia Health
Satori Cyber Ltd.
Tempus
nference
Ciox Health
HealthVerity
Zebra Medical Vision
Huma Therapeutics
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
De-identified Health Data Market, By Type of Data
De-identified Health Data Market, By Application
De-identified Health Data Market, By End User
De-identified Health Data Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. De-identified Health Data Market, By Type of Data, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Clinical Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Genomic Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Patient Demographics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Prescription Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Claims Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Behavioral Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Wearable and Sensor Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Survey and Patient-Reported Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Imaging Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laboratory Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Social Determinants of Health (SDOH) Data
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. De-identified Health Data Market, By Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Clinical Research and Trials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Public Health
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Precision Medicine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Health Economics and Outcomes Research (HEOR)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Population Health Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Drug Discovery and Development
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Healthcare Quality Improvement
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Insurance Underwriting and Risk Assessment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. De-identified Health Data Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Biotechnology Firms
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Healthcare Providers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Insurance Companies/Healthcare Payers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Research Institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Government Agencies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. De-identified Health Data Market, By Region, 2020 - 2032, (USD Bn)
Introduction
Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
Latin America
Introduction
Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Type of Data, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
South Africa
North Africa
Central Africa
8. Competitive landscape
IQVIA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Oracle (Cerner Corporation)
Merative (Truven Health Analytics)
Optum, Inc.
BioTelemetry, Inc.
Flatiron Health
Veradigm LLC
Medidata Solutions
Evidation Health, Inc.
Komodo Health, Inc.
Sundown Solutions, LLC
Clarify Health Solutions
Akrivia Health
Satori Cyber Ltd.
Tempus
nference
Ciox Health
HealthVerity
Zebra Medical Vision
Huma Therapeutics
9. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us